Antiretroviral therapy suppresses HIV to undetectable levels, which both preserves the immune system and means the virus cannot be passed on sexually. Modern treatment is usually a single daily tablet combining several drugs that block different stages of the viral life cycle — most often built around an integrase inhibitor, which stops HIV inserting its genetic material into human DNA.
Class descriptions are written by the Priya Life Science editorial team. Individual drug pages combine that summary with live label, approval, manufacturer and shortage data from the U.S. FDA via the openFDA API. This page is general information and is not medical advice — it is not exhaustive, drugs within a class are not automatically interchangeable, and approvals and brand names differ between the US, EU/Ireland (EMA/HPRA) and other regions. Always consult the official prescribing information and your clinician or pharmacist. Related: Drug Shortages Tracker · FDA Approvals · All drug comparisons